Showing results (661-670 of 1,299) with videos related to

Sort By:
Pageof 130
Respiratory Investigation|June 29, 2019
Pre-existing interstitial lung abnormalities are risk factors for immune checkpoint inhibitor-induced interstitial lung disease in non-small cell lung cancerYu Nakanishi, Takeshi Masuda, Kakuhiro Yamaguchi, et al.
Respiratory Investigation|February 19, 2022
Machine learning to distinguish lymphangioleiomyomatosis from other diffuse cystic lung diseasesAndrea Jonas, Michael Muelly, Nishant Gupta, et al.
Respiratory Investigation|April 10, 2022
Limited efficacy of nintedanib for idiopathic pleuroparenchymal fibroelastosisYoshiaki Kinoshita, Takuto Miyamura, Takato Ikeda, et al.
Respiratory Investigation|August 28, 2016
Pirfenidone: Clinical trials and clinical practice in patients with idiopathic pulmonary fibrosisMasashi Bando
Respiratory Investigation|April 20, 2019
Recent trends in the treatment of unresectable stage III non-small-cell lung cancerGo Makimoto, Katsuyuki Hotta, Katsuyuki Kiura
Respiratory Investigation|November 26, 2016
A retrospective cohort study of outcome in systemic sclerosis-associated interstitial lung diseaseMasaki Okamoto, Kiminori Fujimoto, Junko Sadohara, et al.
Respiratory Investigation|November 26, 2016
Tolerability and efficacy of afatinib at a low starting dosage in 10 elderly or low performance status patients with advanced refractory non-small-cell lung cancerKosuke Kashiwabara, Hiroshi Semba, Shinji Fujii, et al.
Respiratory Investigation|August 6, 2020
Prevalence of viral infection in acute exacerbation of interstitial lung diseases in JapanRintaro On, Takemasa Matsumoto, Hisako Kushima, et al.
Respiratory Investigation|April 1, 2021
Real-world treatment and health care resource use among severe asthma patients in JapanYasuo To, Yurie Taguchi, Tatsuya Shimazaki, et al.
Respiratory Investigation|March 30, 2021
Pharmacokinetics and clinical outcomes of nivolumab administered every 4 weeks in patients with advanced non-small-cell lung cancer: A four-case pilot studyKei Irie, Akira Okada, Shoji Fukushima, et al.
Pageof 130